Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
Q2 2021 vs. Q1 2021
How the institutions holding Alexion Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 755 | 9 | 711 | −35 |
| Shares | 204.6M | 1.49M | 212.2M | +9.05M (+4.5%) |
| Value | $31.3B | $227.3M | $39.1B | +$8.00B (+25.8%) |
9 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (67)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (102)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
Showing the largest 100 of 102 by value.
Not filed for Q2 2021 yet (9)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Omni Partners LLP | 1,003,383 | $153.4M |
| Amundi Asset Management US, Inc. | 454,408 | $69.5M |
| Pillar Pacific Capital Management LLC | 10,405 | $1.59M |
| Tealwood Asset Management Inc | 8,380 | $1.28M |
| E Fund Management Co., Ltd. | 4,159 | $636.0K |
| Rikoon Group, LLC | 2,644 | $404.0K |
| WealthStone, Inc. | 1,608 | $245.0K |
| BBVA USA Bancshares, Inc. | 1,543 | $236.0K |
| CSat Investment Advisory, L.P. | 163 | $25.0K |